Li Jing-Xin - National Health Commission (NHC) Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention

Chris Wynne, Abundio Balgos,Jingxin Li, Paul Hamilton,Louie Tirador, Anjuli May Jaen,Chen Mo, Zijing Yue, Ying Ma, Qingshuang Wang, Rendu Wen, Zheng Yao,

Infectious Diseases and Therapyno. 1 (2024): 57-78

Cited0Views0WOSBibtex

Even a Small Stride Can Have a Significant Impact: Enhancing the Effectiveness of Influenza Vaccines

Wang Weixiao,Li Jingxin

Infectious Diseases & Immunityno. 2 (2024): 56-57

Cited0Views0Bibtex

Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study

Siyue Jia,Zundong Yin,Hongxing Pan,Fuzhen Wang,Xiaoqiang Liu, Qing Wang,Li Zhang, Jihai Tang, Hao Yang,Jiangbo Du, Zhiguo Wang,Pengfei Jin,

EMERGING MICROBES & INFECTIONS（2024）

Cited0Views0WOSBibtex

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies

Abundio Balgos,Suad Hannawi, Wen-Li Chen,Alaa Abuquta,Linda Safeldin,Aala Hassan,Ahmad Alamadi,Louie Tirador, Anjuli May Jaen, Ralph Elvi Villalobos,Chen Mo, Zi-Jing Yue,

EXPERT REVIEW OF VACCINESno. 1 (2024): 419-431

Cited0Views0WOSBibtex

Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial

Yawen Zhu,Rong Tang, Xiaolong Li,Xiaoqin Chen,Xue Wang, Ying Wang,Ruijie Wang,Fengcai Zhu,Jingxin Li

VACCINESno. 3 (2024)

Cited0Views0Bibtex

Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

Chris Wynne, Abundio Balgos,Jingxin Li, Paul Hamilton,Louie Tirador, Anjuli May Jaen, Chen Mo, Zijing Yue, Ying Ma, Qingshuang Wang, Rendu Wen, Zheng Yao,

Infectious Diseases and Therapypp.1-2, (2024)

Cited0Views0WOSBibtex

Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial

Yan-Fei Wu,Ming-Wei Wei,Rui-Jie Wang,Xi-Ling Guo,Hong-Xing Pan, Ya-Chun Gao,Xiao-Long Li,Xue Wang, Xiao-Min Ma,Peng Wan, Li Zhou,Ya-Wen Zhu,

Expert review of vaccinesno. 1 (2023): 662-670

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn